Net Cash Provided by (Used in) Financing Activities in USD of ALIMERA SCIENCES INC from 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alimera Sciences Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2024.
  • Alimera Sciences Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.97M, a 70.3% decline year-over-year.
  • Alimera Sciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $96.5M.
  • Alimera Sciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$302K, a 103% decline from 2021.
  • Alimera Sciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $9.82M, a 153% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

ALIMERA SCIENCES INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.97M -$7.03M -70.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $10M +$10.1M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 -$62K -$5K -8.77% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 -$57K -$2.47M -102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $2.42M +$2.53M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 -$110K -$1.34M -109% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $1.23M +$1.27M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$38K +$428K +91.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 -$466K -$261K -127% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q1 2015 -$205K -$35.2M -101% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q1 2014 $35M +$35.4M Jan 1, 2014 Mar 31, 2014 8-K 2015-09-18
Q1 2013 -$462K +$109K +19.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 -$571K -$681K -619% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $110K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11

ALIMERA SCIENCES INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $96.5M +$96.8M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$302K -$10.1M -103% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $9.82M +$5.94M +153% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $3.88M +$3.01M +347% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $869K -$81K -8.53% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-05
2018 $950K -$4.77M -83.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $5.72M -$19.7M -77.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-25
2016 $25.4M +$24.8M +3968% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-02
2015 $625K -$114M -99.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-03
2014 $115M +$113M +6837% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $1.65M -$35.5M -95.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $37.2M +$37.6M Jan 1, 2012 Dec 31, 2012 10-K 2014-03-07
2011 -$410K -$68.6M -101% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-28
2010 $68.2M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.